Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus
about
Clinical Usefulness of ArbekacinArbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureusOptimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulationThe usefulness of arbekacin compared to vancomycin.Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary studyPharmacological considerations for the proper clinical use of aminoglycosides.Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity.
P2860
Q26751041-0DD95BEA-2DCB-4283-ABC7-88D87BC060B5Q34442603-F7B51C64-A0C3-4283-8466-1F09CE896705Q35127932-509244B6-3FEA-4782-9425-3DF524FD3A18Q35644095-9AD09579-343C-4CC5-B025-54A40C72B927Q35999171-4462140E-2F15-4CF7-9E4D-A14B8B8310F0Q36175569-34410011-D391-471D-B1AF-AB962BAFCE1EQ37192126-4FA26937-7E83-469E-8FE1-928EBCD8F09DQ37956403-D65424E9-6185-499A-A77A-B8A24E7108D7Q40401622-57F170D2-FDF3-4749-BEBF-BF8E961A8359Q41976880-5D0BBB1A-CA7B-4725-9A22-B1BB28F72619Q53192571-79B2DB09-8E06-4F5F-9A2C-02078B1B7221
P2860
Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@ast
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@en
type
label
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@ast
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@en
prefLabel
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@ast
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@en
P2093
P2860
P356
P1476
Pharmacokinetic-pharmacodynami ...... esistant Staphylococcus aureus
@en
P2093
Kihachiro Shimizu
Mitsuo Kaku
Naoki Aikawa
Reiko Sato
Yusuke Tanigawara
P2860
P304
P356
10.1128/AAC.00480-05
P407
P577
2006-11-01T00:00:00Z